Shield Therapeutics PLC STX.L
GBX5.30 GBX0.05 (0.95%) 1D
Last Updated: Oct 09, 12:00 AM·LSE
Pricing for GB stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
News
Pricing
Company
About Musaffa
Investors
Build with us
Is Shield Therapeutics PLC Stock Halal?
Shariah Compliance Analysis of STX.L Stock
United Kingdom Health Care Micro Cap No. As of October 2026, Shield Therapeutics PLC (STX.L) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Shield Therapeutics PLC does not pass Musaffa's business and financial screening criteria.
Shield Therapeutics Plc is a commercial stage specialty pharmaceutical company, which engages in addressing iron deficiency with its lead product Accrufer. The firm delivers differentiated specialty pharmaceuticals that address a significant unmet need for patients suffering from iron deficiency, with or without anemia. The Company’s lead product, Accrufer/Feraccru, is broadly indicated for use in adults across multiple therapeutic categories. Ferric maltol is approved in the United States, European Union, the United Kingdom, Canada, Australia and Switzerland for the treatment of iron deficiency with or without anemia in adults. The company also has an exclusive licence agreement with Beijing Aosaikang Pharmaceutical Co., Ltd., for the development and commercialization of ACCRUFeR/FeRACCRU in China, Hong Kong, Macau and Taiwan, with Korea Pharma Co., Ltd. for the Republic of Korea. The firm's subsidiaries include Phosphate Therapeutics Limited, Shield TX (Switzerland) AG, Shield Therapeutics Inc, and Shield TX (UK) Limited.
STX.L Shariah Compliance
Screening Methodology: AAOIFI
As of October 2026, Shield Therapeutics PLC is classified as not halal.
NOT HALALShield Therapeutics PLC (STX.L) Chart
Fetching Price Chart...
Financial Metrics & Statements of Shield Therapeutics PLC (STX.L)
FAQ's for Shield Therapeutics PLC (STX.L)
- As of October 2026, Shield Therapeutics PLC STX.L is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Shield Therapeutics PLC using these criteria to determine its compliance status.
- Muslim investors may consider investing in Shield Therapeutics PLC if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Shield Therapeutics PLC by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Shield Therapeutics PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Shield Therapeutics PLC on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Shield Therapeutics PLC (STX.L)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
